Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

Kay-Oliver Kliche; Konstantin Kubsch; Martin Raida; Rami Masri-Zada; Klaus Höffken

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

【24h】

Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

机译：5-FU和亚叶酸钠与奥沙利铂，伊立替康或吉西他滨合用的转移性胃肠道癌的定时化疗：耶拿79例的经验。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Abstract

机译：抽象

著录项

来源
《Journal of Cancer Research and Clinical Oncology 》 |2002年第9期| 516-524| 共9页
作者
Kay-Oliver Kliche; Konstantin Kubsch; Martin Raida; Rami Masri-Zada; Klaus Höffken;
展开▼
作者单位

Department of Internal Medicine II Friedrich-Schiller University Erlanger Allee 101 07740 Jena Germany;

Department of Internal Medicine II Friedrich-Schiller University Erlanger Allee 101 07740 Jena Germany;

Department of Internal Medicine II Friedrich-Schiller University Erlanger Allee 101 07740 Jena Germany;

Department of Internal Medicine I Friedrich-Schiller University Jena Germany;

Department of Internal Medicine II Friedrich-Schiller University Erlanger Allee 101 07740 Jena Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Chronotherapy Colorectal cancer Oxaliplatin Irinotecan Sodium folinate;

机译：慢性疗法大肠癌奥沙利铂伊立替康亚叶酸钠;

相似文献

外文文献
中文文献
专利

1. Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients. [J] . Kliche KO, Kubsch K, Raida M, Journal of Cancer Research and Clinical Oncology . 2002 ,第9期

机译：5-FU和亚叶酸钠与奥沙利铂，伊立替康或吉西他滨合用的转移性胃肠道癌的定时化疗：耶拿79例的经验。
2. Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation. [J] . Farker K, Merkel U, Wedding U, International journal of clinical pharmacology and therapeutics . 2006 ,第1期

机译：用奥沙利铂，5-FU和亚叶酸钠对转移性胃肠道癌症患者进行定时化疗：在初步研究中对非血液学毒性和患者特征的原始分析。
3. Pharmacokinetics of oxaliplatin and non-hematological toxicity in metastatic gastrointestinal cancer patients treated with chronomodulated oxaliplatin, 5-FU and sodium folinate in a pilot investigation. [J] . Merkel U, Farker K, Wedding U, International journal of clinical pharmacology and therapeutics . 2006 ,第3期

机译：在先导研究中，草酸奥沙利铂，5-FU和亚叶酸钠治疗的转移性胃肠道癌症患者的奥沙利铂药代动力学和非血液学毒性。
4. Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial [O] . Pasquale F. Innominato, Annabelle Ballesta, Qi Huang, 2020

机译：伊立替康与性别依赖的最低毒性时机联合计时性化疗治疗转移性结直肠癌：随机多中心EORTC 05011试验
5. PCN150 - COST-EFFECTIVENESS ANALYSIS OF PHARMACOKINETIC-GUIDED (PK) 5-FLUOROURACIL (5-FU) DOSING WHEN COMBINED WITH LEUCOVORIN, IRINOTECAN AND OXALIPLATIN (FOLFIRINOX) CHEMOTHERAPY FOR ADVANCED PANCREAS CANCER [O] . A. Egues, A. Aldaz, J. Rodriguez, 2018

机译：PCN150 - 药代动力学引导（PK）5-氟尿嘧啶（5-FU）与晚期胰腺癌的化疗结合出生胰岛素（FOLFIRINOX）化疗时的药代动力学引导（PK）5-氟尿嘧啶（5-FU）的成本效益分析

Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.

摘要

著录项

相似文献

相关主题

期刊订阅